SAFETY PROFILE CHARACTERIZED IN

LARGE CLINICAL TRIALS1

VIBATIV has been studied extensively in some of the largest clinical registration trials of any anti-MRSA agent for cSSSI or HABP/VABP.

HABP/VAPB
cSSSI

No drug interactions were observed.